DISEASE SCANNER
Global Incurable Diseases Tracker
Warm Autoimmune Hemolytic Anemia (wAIHA)
A condition where the body's immune system mistakenly attacks and destroys its own red blood cells, causing anemia. IgG antibodies react at body temperature.
80.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Complete blood count (anemia)
- 2Reticulocyte count (elevated)
- 3Peripheral blood smear (spherocytes)
- 4Direct antiglobulin test (DAT/Coombs)
- 5LDH and bilirubin (elevated)
- 6Haptoglobin (decreased)
Prognosis
Variable. 70-80% respond to initial corticosteroids. 20-30% achieve sustained remission off steroids. Relapse common when steroids tapered. Rituximab effective in 60-70% of refractory cases. Splenectomy effective in 60-80%. Overall 5-year survival 70-80%. Secondary wAIHA (associated with CLL/lymphoma) has worse prognosis. Severe anemia can be life-threatening.
Prevention
- No known prevention
- Avoid triggering medications
- Vaccinations before splenectomy
- Regular monitoring of hemoglobin
Research Status
First-line corticosteroids, rituximab for steroid-sparing or refractory disease. Splenectomy for selected patients. Immunosuppressants (azathioprine, cyclophosphamide). Fostamatinib recently approved.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK459335
- https://www.hematology.org/education/patients/anemia/autoimmune-hemolytic-anemia
- https://rarediseases.org/rare-diseases/warm-antibody-hemolytic-anemia
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.